[31] displayed that circulating ACE2 activities were increased in patients with heart failure and hypertension, while ACE2 reduced with the amelioration of the heart failure after Cardiac resynchronization therapy (CRT) [31]. The gene discussed is ACE2; the disease is Hypertension.